GO

Site funding provided by:  Telecris Biotheraputics

IDF's Mission

The Immune Deficiency Foundation is the National Patient Organization Dedicated to Improving the Diagnosis, Treatment and Quality of Life of Persons with Primary Immunodeficiency Diseases through Advocacy, Education, and Research

In the News

Proposed Acquisition of Talecris by CSL Limited
A proposed combination of Talecris Biotherapeutics and CSL Behring, has been announced.
August 13, 2008
IDF Announces the Launch of New Web Site
IDF officially launched new Web site
July 2008
'Fog of Illness' Never Seemed to Go Away
Lack of antibodies makes it harder for sufferers of CVID to fight off infections.
June 2008
Senate Introduces S. 2990
IDF Applauds Legislation to Improve Patient Access to Life Saving IVIG Treatment
May 2008
More News
IDF Family Retreats
IDF Family Retreats
Spotlight on Primary Immunodeficiency

Hueston Woods Resort
College Corner, Ohio
Sept. 5-7, 2008
Register Now!
IDF Action Alert
IDF Action Alert
New CMS proposal likely to negatively impact our community.

Please help us in responding to CMS.
Take Action!
Support the IDF
Support the IDF
If you received a check from the government this spring, please consider making a charitable contribution to IDF. Your support is critical to our success!
Click Here to Help